Cell - Citizens For Ecological Learning & Living

Cell - Citizens For Ecological Learning & Living company information, Employees & Contact Information

Since its creation in 2010, CELL has been creating and supporting local and regional ecological and social transition projects, such as community gardens, third places, Repair Cafés, eco-social entrepreneurship and energy cooperatives.
Looking for a particular Cell - Citizens For Ecological Learning & Living employee's phone or email?

Cell - Citizens For Ecological Learning & Living Questions

News

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment - Nature

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment Nature

Non-Small Cell Lung Cancer (NSCLC): Background, Pathophysiology, Etiology - Medscape eMedicine

Non-Small Cell Lung Cancer (NSCLC): Background, Pathophysiology, Etiology Medscape eMedicine

NICE recommends first immunotherapy for limited-stage small cell lung cancer - The Pharmaceutical Journal

NICE recommends first immunotherapy for limited-stage small cell lung cancer The Pharmaceutical Journal

Comparative Analysis of Cell Damage Induced by Lu-177 and Tb-161: Insights into Auger Electrons and Therapeutic Efficiency - Journal of Nuclear Medicine

Comparative Analysis of Cell Damage Induced by Lu-177 and Tb-161: Insights into Auger Electrons and Therapeutic Efficiency Journal of Nuclear Medicine

Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer - Frontiers

Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer Frontiers

ALK and Lung Cancer - American Lung Association

ALK and Lung Cancer American Lung Association

Neoadjuvant Aumolertinib for unresectable stage III EGFR -mutant non-small cell lung cancer: a single-arm phase II trial - Nature

Neoadjuvant Aumolertinib for unresectable stage III EGFR -mutant non-small cell lung cancer: a single-arm phase II trial Nature

Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis - Frontiers

Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis Frontiers

LU joins Agenda 2030 with new cell for SDGs - Times of India

LU joins Agenda 2030 with new cell for SDGs Times of India

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial - The Lancet

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial The Lancet

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer The New England Journal of Medicine

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity - ScienceDirect.com

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity ScienceDirect.com

Trajectories of Perioperative Serum CEA and Non-Small Cell Lung Cancer Prognosis: A Retrospective Longitudinal Cohort Study - Frontiers

Trajectories of Perioperative Serum CEA and Non-Small Cell Lung Cancer Prognosis: A Retrospective Longitudinal Cohort Study Frontiers

Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial - Nature

Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial Nature

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study - Journal of Nuclear Medicine

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study Journal of Nuclear Medicine

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer - Nature

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer Nature

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer - Frontiers

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer Frontiers

Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials - Nature

Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials Nature

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer - Nature

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer Nature

-mutated nonsmall-cell lung cancer: a phase 2b trial - Nature

-mutated nonsmall-cell lung cancer: a phase 2b trial Nature

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer - Nature

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer Nature

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer - The New England Journal of Medicine

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer The New England Journal of Medicine

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer The New England Journal of Medicine

Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer - Dove Medical Press

Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer Dove Medical Press

Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance - Frontiers

Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance Frontiers

MEK inhibitors for the treatment of non-small cell lung cancer - Journal of Hematology & Oncology

MEK inhibitors for the treatment of non-small cell lung cancer Journal of Hematology & Oncology

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer The New England Journal of Medicine

Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis - Nature

Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis Nature

Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer - Nature

Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer Nature

Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy - Frontiers

Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy Frontiers

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer The New England Journal of Medicine

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future? - Frontiers

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future? Frontiers

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer The New England Journal of Medicine

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer - The New England Journal of Medicine

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer The New England Journal of Medicine

Single-Cell Analysis of Human Retina Identifies Evolutionarily Conserved and Species-Specific Mechanisms Controlling Development - ScienceDirect.com

Single-Cell Analysis of Human Retina Identifies Evolutionarily Conserved and Species-Specific Mechanisms Controlling Development ScienceDirect.com

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma - Nature

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma Nature

Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer - Nature

Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer Nature

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR - The New England Journal of Medicine

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR The New England Journal of Medicine

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors - Nature

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors Nature

Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment - Cleveland Clinic

Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment Cleveland Clinic

Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes - Nature

Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes Nature

What Is Your Outlook When SCLC Spreads to the Brain? - Healthline

What Is Your Outlook When SCLC Spreads to the Brain? Healthline

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients - Nature

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients Nature

T Cell-Released Extracellular Vesicles Potentiate the Efficacy of the HBsAg Vaccine by Enhancing B Cell Responses - Wiley Online Library

T Cell-Released Extracellular Vesicles Potentiate the Efficacy of the HBsAg Vaccine by Enhancing B Cell Responses Wiley Online Library

New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe - The Lancet

New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe The Lancet

GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence - Frontiers

GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence Frontiers

MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis - Frontiers

MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis Frontiers

Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity - Nature

Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity Nature

Metastatic lung cancer life expectancy: Survival rates and more - Medical News Today

Metastatic lung cancer life expectancy: Survival rates and more Medical News Today

Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells - Nature

Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells Nature

Prognostic and predictive factors for lung cancer - ERS - European Respiratory Society

Prognostic and predictive factors for lung cancer ERS - European Respiratory Society

Risk Factors and Treatment of Squamous Cell Carcinoma in the Lungs - Verywell Health

Risk Factors and Treatment of Squamous Cell Carcinoma in the Lungs Verywell Health

Expansion of the Hadley cell under global warming - Lu - 2007 - Geophysical Research Letters - AGU Publications

Expansion of the Hadley cell under global warming - Lu - 2007 - Geophysical Research Letters AGU Publications

Top Cell - Citizens For Ecological Learning & Living Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant